为您找到相关结果约73个

你是不是要搜索 期刊Ropeginterferon 点击跳转

Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera

Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of vera

A Case Report of Ropeginterferon Alfa-2b for Polycythemia Vera during Pregnancy

Population Pharmacokinetics of Ropeginterferon Alfa-2b: A Comparison Between Healthy Caucasian and Chinese

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Use of ropeginterferon in inducing graft versus myelofibrosis effect in post-transplant myelofibrosis

Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C

Pharmacokinetics and Pharmacodynamics of Novel Long-Acting Ropeginterferon Alfa-2b in Healthy Chinese

Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative

Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I

A case of polycythaemia vera treated with ropeginterferon-2b during pregnancy

Ropeginterferon Demonstrates Safety and Efficacy in Myelofibrosis: Pilot Study Results

Immunomodulatory and direct activities of ropeginterferon alfa-2b on cancer cells in mouse models of

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

为您找到相关结果约73个

共73条页码: 1/5页15条/页